Annual Working Capital
$34.37 M
-$31.27 M-47.63%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual working capital is $34.37 million, with the most recent change of -$31.27 million (-47.63%) on December 31, 2023.
- During the last 3 years, CUE annual working capital has fallen by -$36.84 million (-51.73%).
- CUE annual working capital is now -51.73% below its all-time high of $71.21 million, reached on December 31, 2020.
Performance
CUE Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$20.47 M
+$3.02 M+17.34%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly working capital is $20.47 million, with the most recent change of +$3.02 million (+17.34%) on September 30, 2024.
- Over the past year, CUE quarterly working capital has increased by +$3.02 million (+17.34%).
- CUE quarterly working capital is now -74.20% below its all-time high of $79.34 million, reached on September 30, 2020.
Performance
CUE Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CUE Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.6% | +17.3% |
| 3 y3 years | -51.7% | -68.8% |
| 5 y5 years | -0.1% | -68.8% |
CUE Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.6% | at low | -68.8% | +17.3% |
| 5 y | 5-year | -51.7% | at low | -74.2% | +17.3% |
| alltime | all time | -51.7% | +457.6% | -74.2% | +823.6% |
Cue Biopharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.47 M(+17.3%) |
| Jun 2024 | - | $17.44 M(-34.4%) |
| Mar 2024 | - | $26.58 M(-22.7%) |
| Dec 2023 | $34.37 M(-47.6%) | $34.37 M(-14.7%) |
| Sep 2023 | - | $40.31 M(-9.7%) |
| Jun 2023 | - | $44.63 M(-18.8%) |
| Mar 2023 | - | $54.95 M(-16.3%) |
| Dec 2022 | $65.64 M(+17.9%) | $65.64 M(+27.5%) |
| Sep 2022 | - | $51.48 M(-15.2%) |
| Jun 2022 | - | $60.68 M(-6.0%) |
| Mar 2022 | - | $64.54 M(+15.9%) |
| Dec 2021 | $55.68 M(-21.8%) | $55.68 M(+1.4%) |
| Sep 2021 | - | $54.90 M(-12.9%) |
| Jun 2021 | - | $63.00 M(+3.7%) |
| Mar 2021 | - | $60.77 M(-14.7%) |
| Dec 2020 | $71.21 M | $71.21 M(-10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $79.34 M(+8.0%) |
| Jun 2020 | - | $73.49 M(+88.0%) |
| Mar 2020 | - | $39.10 M(-20.8%) |
| Dec 2019 | $49.37 M(+43.5%) | $49.37 M(+118.5%) |
| Sep 2019 | - | $22.60 M(+21.5%) |
| Jun 2019 | - | $18.60 M(-13.1%) |
| Mar 2019 | - | $21.39 M(-37.8%) |
| Dec 2018 | $34.39 M(-42.4%) | $34.39 M(-4.5%) |
| Sep 2018 | - | $36.03 M(-22.2%) |
| Jun 2018 | - | $46.29 M(-10.7%) |
| Mar 2018 | - | $51.84 M(-13.2%) |
| Dec 2017 | $59.72 M(+324.4%) | $59.72 M(+2595.0%) |
| Sep 2017 | - | $2.22 M(-66.4%) |
| Jun 2017 | - | $6.59 M(-53.2%) |
| Dec 2016 | $14.07 M(+128.3%) | $14.07 M |
| Dec 2015 | $6.16 M | - |
FAQ
- What is Cue Biopharma annual working capital?
- What is the all time high annual working capital for Cue Biopharma?
- What is Cue Biopharma annual working capital year-on-year change?
- What is Cue Biopharma quarterly working capital?
- What is the all time high quarterly working capital for Cue Biopharma?
- What is Cue Biopharma quarterly working capital year-on-year change?
What is Cue Biopharma annual working capital?
The current annual working capital of CUE is $34.37 M
What is the all time high annual working capital for Cue Biopharma?
Cue Biopharma all-time high annual working capital is $71.21 M
What is Cue Biopharma annual working capital year-on-year change?
Over the past year, CUE annual working capital has changed by -$31.27 M (-47.63%)
What is Cue Biopharma quarterly working capital?
The current quarterly working capital of CUE is $20.47 M
What is the all time high quarterly working capital for Cue Biopharma?
Cue Biopharma all-time high quarterly working capital is $79.34 M
What is Cue Biopharma quarterly working capital year-on-year change?
Over the past year, CUE quarterly working capital has changed by +$3.02 M (+17.34%)